FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898483775> ?p ?o ?g. }

• W2898483775 endingPage "1126" @default.
• W2898483775 startingPage "1126" @default.
• W2898483775 abstract "<h3>Importance</h3> Intake of dietary docosahexaenoic acid (DHA) among toddlers is low. Supplementation may benefit developmental outcomes of toddlers who were born preterm. <h3>Objective</h3> To determine whether 6 months of daily DHA supplementation improves developmental outcomes of toddlers who were born preterm. <h3>Design, Setting, and Participants</h3> A randomized, fully masked, placebo-controlled trial was conducted from April 26, 2012, to March 24, 2017, at a large US pediatric academic center with 9 neonatal intensive care units. Children born at less than 35 weeks’ gestation who were 10 to 16 months corrected age underwent 6 months of intervention. Of 4142 children assessed, 1549 were eligible, 1172 declined, and 377 enrolled and were randomized. Analyses were according to intent to treat. <h3>Interventions</h3> One-to-one allocation to receive daily microencapsulated DHA, 200 mg, and arachidonic acid (AA), 200 mg (DHA+AA), or microencapsulated corn oil (placebo). <h3>Main Outcomes and Measures</h3> The primary outcome specified a priori was Bayley Scales of Infant and Toddler Development, third edition (Bayley-III), cognitive composite score at 16 to 22 months corrected age. Secondary outcomes were Bayley-III language and motor composite scores and Infant Behavior Questionnaire–Revised and Early Childhood Behavior Questionnaire effortful control and activity level scores. Subgroup analyses defined a priori were by income, sex, and birth weight. <h3>Results</h3> Among 377 children randomized and included in the analysis (182 girls and 195 boys; median corrected age, 15.7 months), 338 children (89.7%) had complete data on the primary outcome. Bayley-III cognitive scores did not differ between the DHA+AA and placebo groups (difference in change, 0.5 [95% CI, –1.8 to 2.8]; effect size, 0.05;<i>P</i> = .66). Assignment to the DHA+AA group had a small to medium negative effect on Bayley-III language scores among children with lower birth weights (eg, a child with a birth weight of 1000 g assigned to receive DHA+AA experienced a 4.1-point relative decrease, while a child assigned to placebo did not;<i>P</i> = .03 for interaction). Supplementation had a similar negative effect on effortful control scores among children with annual household incomes greater than $35 000 (difference in change, –0.3 [95% CI, –0.4 to –0.1]; effect size, –0.37;<i>P</i> = .01). Bayley-III motor scores and activity level scores were unaffected. <h3>Conclusions and Relevance</h3> Daily supplementation with 200 mg of DHA and 200 mg of AA for 6 months resulted in no improvement in cognitive development and early measures of executive function vs placebo, and may have resulted in negative effects on language development and effortful control in certain subgroups of children. These findings do not support DHA supplementation in the second year of life for children who are born preterm. <h3>Trial Registration</h3> ClinicalTrials.gov Identifier:NCT01576783" @default.
• W2898483775 created "2018-11-02" @default.
• W2898483775 creator A5005411518 @default.
• W2898483775 creator A5009231836 @default.
• W2898483775 creator A5015638413 @default.
• W2898483775 creator A5019804045 @default.
• W2898483775 creator A5027374014 @default.
• W2898483775 creator A5064100926 @default.
• W2898483775 creator A5069231940 @default.
• W2898483775 creator A5071489205 @default.
• W2898483775 creator A5074496148 @default.
• W2898483775 creator A5076748283 @default.
• W2898483775 date "2018-12-01" @default.
• W2898483775 modified "2023-10-03" @default.
• W2898483775 title "Effect of Docosahexaenoic Acid Supplementation vs Placebo on Developmental Outcomes of Toddlers Born Preterm" @default.
• W2898483775 cites W1562647337 @default.
• W2898483775 cites W1904671842 @default.
• W2898483775 cites W1964471367 @default.
• W2898483775 cites W1977721597 @default.
• W2898483775 cites W1984908766 @default.
• W2898483775 cites W1988834613 @default.
• W2898483775 cites W1998496283 @default.
• W2898483775 cites W2007818608 @default.
• W2898483775 cites W2018883062 @default.
• W2898483775 cites W2026489602 @default.
• W2898483775 cites W2031027917 @default.
• W2898483775 cites W2033934773 @default.
• W2898483775 cites W2035182169 @default.
• W2898483775 cites W2036793306 @default.
• W2898483775 cites W2055559957 @default.
• W2898483775 cites W2056449733 @default.
• W2898483775 cites W2057128909 @default.
• W2898483775 cites W2058223996 @default.
• W2898483775 cites W2067031234 @default.
• W2898483775 cites W2069006459 @default.
• W2898483775 cites W2098338770 @default.
• W2898483775 cites W2114628261 @default.
• W2898483775 cites W2121161776 @default.
• W2898483775 cites W2123656192 @default.
• W2898483775 cites W2124141570 @default.
• W2898483775 cites W2125555008 @default.
• W2898483775 cites W2139564895 @default.
• W2898483775 cites W2141732795 @default.
• W2898483775 cites W2143335730 @default.
• W2898483775 cites W2208371567 @default.
• W2898483775 cites W2554662202 @default.
• W2898483775 cites W2621167982 @default.
• W2898483775 cites W2748437598 @default.
• W2898483775 cites W2752032852 @default.
• W2898483775 cites W4239011888 @default.
• W2898483775 cites W4239566419 @default.
• W2898483775 cites W4245045653 @default.
• W2898483775 doi "https://doi.org/10.1001/jamapediatrics.2018.3082" @default.
• W2898483775 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6583023" @default.
• W2898483775 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30357263" @default.
• W2898483775 hasPublicationYear "2018" @default.
• W2898483775 type Work @default.
• W2898483775 sameAs 2898483775 @default.
• W2898483775 citedByCount "35" @default.
• W2898483775 countsByYear W28984837752019 @default.
• W2898483775 countsByYear W28984837752020 @default.
• W2898483775 countsByYear W28984837752021 @default.
• W2898483775 countsByYear W28984837752022 @default.
• W2898483775 countsByYear W28984837752023 @default.
• W2898483775 crossrefType "journal-article" @default.
• W2898483775 hasAuthorship W2898483775A5005411518 @default.
• W2898483775 hasAuthorship W2898483775A5009231836 @default.
• W2898483775 hasAuthorship W2898483775A5015638413 @default.
• W2898483775 hasAuthorship W2898483775A5019804045 @default.
• W2898483775 hasAuthorship W2898483775A5027374014 @default.
• W2898483775 hasAuthorship W2898483775A5064100926 @default.
• W2898483775 hasAuthorship W2898483775A5069231940 @default.
• W2898483775 hasAuthorship W2898483775A5071489205 @default.
• W2898483775 hasAuthorship W2898483775A5074496148 @default.
• W2898483775 hasAuthorship W2898483775A5076748283 @default.
• W2898483775 hasBestOaLocation W28984837751 @default.
• W2898483775 hasConcept C103728769 @default.
• W2898483775 hasConcept C118552586 @default.
• W2898483775 hasConcept C126322002 @default.
• W2898483775 hasConcept C138496976 @default.
• W2898483775 hasConcept C142724271 @default.
• W2898483775 hasConcept C15744967 @default.
• W2898483775 hasConcept C164953862 @default.
• W2898483775 hasConcept C168563851 @default.
• W2898483775 hasConcept C169900460 @default.
• W2898483775 hasConcept C178790620 @default.
• W2898483775 hasConcept C185592680 @default.
• W2898483775 hasConcept C187212893 @default.
• W2898483775 hasConcept C19038510 @default.
• W2898483775 hasConcept C204787440 @default.
• W2898483775 hasConcept C27081682 @default.
• W2898483775 hasConcept C2777171753 @default.
• W2898483775 hasConcept C2778242525 @default.
• W2898483775 hasConcept C2778376644 @default.
• W2898483775 hasConcept C2779234561 @default.
• W2898483775 hasConcept C46973012 @default.
• W2898483775 hasConcept C543025807 @default.
• W2898483775 hasConcept C54355233 @default.

• next